Isradipine

Known as: 3,5-Pyridinedicarboxylic acid, 4-(4-benzofurazanyl)-1,4-dihydro-2,6-dimethyl-, methyl 1-methylethyl ester, Isradipino, Isradipinum

A dihydropyridine calcium channel blockers with antihypertensive and vasodilator activities. Isradipine blocks the calcium entry through the calcium…

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.

2017

The content of this investigation was to study the influence of β-cyclodextrin and hydroxy propyl-β-cyclodextrin complexation on…

2003

Isradipine is a calcium channel blocker approved for the treatment of angina pectoris and hypertension. Transdermal delivery is…

1992

The long-term hemodynamic and antihypertensive effects of isradipine were investigated in 11 patients who had normal renal…

1991

Dr. Y. Pirson, Cliniques Universitaires St. Luc, Department of Nephrology, Avenue Hippocrate 10, B-1200 Brussels (Belgium) Dear…

1991

Nine pregnant women (aged 28.7 +/- 6.9 years) who had developed hypertension (blood pressure greater than 140/90 mm Hg) took part…

1990

The modification of endothelin effects by the calcium antagonist isradipine was investigated by infusion of 1.0 n M/kg endothelin…

1990

The new calcium antagonist isradipine was compared with nifedipine retard in a multicenter, double-blind, placebo-controlled…

1990

Seventeen middle-aged males with sustained essential hypertension (WHO stage II) and diastolic blood pressures (BP) exceeding 100…

1989

Isradipine (PN 200–110) is a new dihydropyridine calcium-entry blocker with powerful vasodilating properties. Therapeutic…

1988

Dihydropyridine calcium antagonists such as isradipine (PN200–110) selectively increase blood flow to the heart, brain, and…